Strategic Partnerships Long-standing distribution relationships with Dr. Falk Pharma and BioGaia, plus exclusive distribution for Translumina, show reliable go-to-market channels in Europe and readiness to expand with new products or territories.

Expansion Momentum Recent acquisitions such as AllergyCare and Neomed demonstrate a growth-driven strategy and integration capability, signaling openness to widen product categories and geographic reach and creating opportunities for new supplier partnerships.

Diversified Portfolio A multi-vertical portfolio across hair care, antivirals, allergy care, cardiovascular devices, and oncology partnerships provides cross-selling possibilities and broad audience reach. Potential sales opportunities include introducing complementary lines and co-licensing agreements.

Regional Focus Schaffhausen-based Ewopharma targets Central Eastern Europe markets and participates in the RX-Alliance, offering a broad regional network and regulatory know-how. Sales opportunity: leverage network to accelerate market access for new therapies and provide regional marketing and regulatory support.

Digital Capabilities Adoption of digital tools and AI-ready tech stack (OpenAI, Meta Ads Manager, Brevo) suggests openness to data-driven marketing and customer engagement. Sales opportunity: offer AI-powered market research, targeted campaigns, and digital enablement services to scale brand presence in CE markets.